{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T02:04:00Z","timestamp":1772762640315,"version":"3.50.1"},"reference-count":0,"publisher":"Frontline Medical Communications, Inc.","issue":"2 Suppl","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.12788\/cutis.0572","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T14:18:03Z","timestamp":1663942683000},"source":"Crossref","is-referenced-by-count":1,"title":["Guidance From the National Psoriasis Foundation COVID-19 Task Force"],"prefix":"10.12788","volume":"110","author":[{"family":"Weinberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5043","container-title":["Cutis"],"original-title":[],"link":[{"URL":"https:\/\/cdn.mdedge.com\/files\/s3fs-public\/CT110002S007.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T14:18:04Z","timestamp":1663942684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdedge.com\/dermatology\/article\/256942\/psoriasis\/guidance-national-psoriasis-foundation-covid-19-task-force"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":0,"journal-issue":{"issue":"2 Suppl","published-print":{"date-parts":[[2022,8]]}},"URL":"https:\/\/doi.org\/10.12788\/cutis.0572","relation":{},"subject":[],"published":{"date-parts":[[2022,8]]}}}